Synthesis, characterization, and cancer cell-selective cytotoxicity of mixed-ligand cobalt(<scp>iii</scp>) complexes of 8-hydroxyquinolines and phenanthroline bases-Reference-Cited by-同舟云学术

Synthesis, characterization, and cancer cell-selective cytotoxicity of mixed-ligand cobalt(iii) complexes of 8-hydroxyquinolines and phenanthroline bases

Published:2024 Issue: Volume: Page:
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Deka Banashree¹,Sarkar Tukki¹,Bhattacharyya Arnab²^ORCID,Butcher Ray J.³^ORCID,Banerjee Samya⁴,Deka Sasanka⁵^ORCID,Saikia Kandarpa K.⁶,Hussain Akhtar¹^ORCID

Affiliation:

1. Department of Chemistry, Handique Girls’ College, Guwahati 781001, Assam, India

2. Department of Inorganic and Physical Chemistry, Indian Institute of Science, Bangalore 560 012, Karnataka, India

3. Department of Chemistry, Howard University, 525 College Street, NW 20059, USA

4. Department of Chemistry, Indian Institute of Technology (BHU), Varanasi, UP 221005, India

5. Department of Chemistry, University of Delhi, New Delhi 110024, India

6. Department of Bioengineering and Technology, GUIST, Gauhati University, Guwahati 781014, Assam, India

Abstract

Transition metal complexes exhibiting selective toxicity towards a broad range of cancer types are highly desirable as potential anticancer agents.

Funder

Department of Biotechnology, Ministry of Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2024/DT/D3DT04045C

Reference71 articles.

1. Platinum-based drugs for cancer therapy and anti-tumor strategies

2. Platinum-based drugs: past, present and future

3. A chemical perspective on the clinical use of platinum-based anticancer drugs

4. The side effects of platinum-based chemotherapy drugs: a review for chemists

5. Unlocking the potential of platinum drugs: organelle-targeted small-molecule platinum complexes for improved anticancer performance